Clinical Trial Update: Safety and Tolerability and Efficacy of LCZ696 in Japanese Hypertensive Patients With Renal Dysfunction [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety, tolerability and efficacy of LCZ696 (sacubitril/valsartan) in Japanese hypertensive patients with renal dysfunction has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypertension

Drugs mentioned

• LCZ696 (sacubitril/valsartan) (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension With Renal Dysfunction | Phase 3 | Status: COMPLETED | Results posted: 2015-08-13